Reports

- Global Locations -

Headquarters

Future Market Insights, Inc.

Christiana Corporate, 200
Continental Drive, Suite 401,
Newark, Delaware - 19713,
United States

T: +1-347-918-3531

Americas

Future Market Insights, Inc.

616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989, United States

MEA

Future Market Insights

1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates

Europe

Future Market Insights

3rd Floor, 207 Regent Street,
W1B 3HH London
United Kingdom

T: + 44 (0) 20 8123 9659

Asia Pacific

Future Market Insights

IndiaLand Global Tech Park, Unit UG-1, Behind Grand HighStreet, Phase 1, Hinjawadi, MH, Pune – 411057, India

Neurostimulation Market Outlook for 2023 to 2033

The global Neurostimulation Market valuation is US$ 6,221.2 million in 2023. The neurostimulation market is expected to grow at a promising CAGR of 9.5% through 2033, with a forecast valuation of US$ 15,417.4 million by 2033. 

Attribute Details
Neurostimulation Market Size, 2022 US$ 5,584.5 million
Neurostimulation Market Size, 2023 US$ 6,221.2 million
Neurostimulation Market Size, 2033 US$ 15,417.4 million
Value CAGR (2023 to 2033) 9.5%

Key Trends Impacting Sales of Neurostimulation Devices

  • Key players are developing neurostimulation devices that can be prescribed by health professionals for remote use. Portable neurostimulation devices for Parkinson's, back pain, etc., have been introduced for faster patient outcomes.
  • Increasing research and development efforts in neurostimulation to arrive at new applications and treat disorders like autism, stroke, sleep disorders, obesity, and several others are predicted to elevate the scope of neurostimulation.
  • Rising demand for technologies that offer better outcomes, optimized inter-device communication, neurological episode on-set, and better user interface.
  • Soaring levels of the geriatric population, with higher risks of neurological disorders like epilepsy, essential tremors, Parkinson’s disease, and depression-related disorders, are predicted to boost the demand for neurostimulation.
  • Increasing acceptance of neurostimulation systems and devices to treat chronic pain, particularly in emerging economies like China, India, Brazil, etc.
  • The rise in the clearance from the FDA for innovative neurostimulators with new applications is enhancing the market scope for neurostimulation.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Historical Growth of the Neurostimulation Market Vs. Forecast Outlook

Attributes Details
Neurostimulation Market Size (2018) US$ 3396.59 million
Neurostimulation Market Size (2022) US$ 5,584.5 million
Neurostimulation Market CAGR (2018 to 2022) 11.4%

The neurostimulation market was valued at US$ 5,584.5 million in 2022, expanding at a CAGR of 11.4% from 2018 to 2022. From 2023 onwards, the growth rate for neurostimulation is predicted to reduce slightly, exhibiting a CAGR of 9.5% through 2033.

The following factors are pushing the market growth.

  • Rising demand for MRI-safe neurostimulation systems to effectively treat several diseases linked with neurotic disorders.
  • Increasing utilization of neurostimulation to treat various debilitating health conditions like Parkinson’s disease, incontinence, depression, gastroparesis, and essential tremors. Healthcare professionals are directing patients without relief from surgical therapies and medications toward neurostimulation as a potential treatment option.
  • By opting for neurostimulation, patients who are extremely paralyzed or enduring intense loss of different sense organs can feel betterment in their quality of life. Thus, neurostimulation is extremely instrumental in hearing aids, artificial limbs, artificial vision, and other prosthetics. 

Comparative View of Adjacent Neurostimulation Markets

Given below is a comparative analysis of the neurostimulation market, the neurodegenerative disease market, and the neuroendocrine carcinoma treatment market. The neurodegenerative disease market is predicted to account for a higher valuation of US$ 50.1 billion in 2023 based on market revenue. With respect to growth rate, the neurostimulation market is estimated to expand at a higher CAGR of 9.5% over the forecast period.

Neurostimulation Market:

Attributes Neurostimulation Market
CAGR (2023 to 2033) 9.5%
Market Value (2023) US$ 6,221.2 million
Growth Factor Increasing cases of neurotic disorders
Future Opportunities Rising demand for improved technology that promotes a better quality of life for patients suffering from neurological disorders
Market Trends Spurring efforts in the research and development activities to lead to breakthroughs

Neurodegenerative Disease Market:

Attributes Neurodegenerative Disease Market
CAGR (2023 to 2033) 7%
Market Value (2023) US$ 50.1 billion
Growth Factor Upsurge in the frequency of neurological diseases
Future Opportunities High potential for growth in the emerging economies of Asia Pacific
Market Trends Growing physician awareness is fueling sales of neurodegenerative disease management drugs

Neuroendocrine Carcinoma Treatment Market:

Attributes Neuroendocrine Carcinoma Treatment Market
CAGR (2023 to 2033) 8%
Market Value (2023) US$ 1.84 billion
Growth Factor Increasing drug approvals are boosting growth in the neuroendocrine carcinoma treatment market
Future Opportunities Rising government initiatives like holding awareness campaigns for early detection of disease
Market Trends Integration of AI to diagnose and treat diseases
Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Category-wise Insights

Spinal Cord Stimulator (SCS) Accounts for a Leading Market Share

Top Product Spinal Cord Stimulator
Market Share (2023) 52.3%

The spinal cord stimulator segment accounts for 52.3% of the market share in 2023. Demand for spinal cord stimulators is rising on account of increasing awareness about the benefits of using this product. The application of spinal cord stimulators is predicted to escalate over the forecast period due to:

  • Increasing geriatric population
  • Rising levels of obesity
  • Surging demand for an alternative to opioids for treatment of diseases
  • Expanding clinical evidence that supports the efficacy of spinal cord stimulator

Substantial Deployment of Neurostimulation for Pain Management 

Top Application Pain Management
Market Share (2023) 45.3%

Neurostimulation in pain management is gaining high traction for treating multiple chronic pain conditions, such as neck pain, migraines, neuropathic pain, arthritis pain, etc. Demand for neurostimulation to control pain is rising due to its effectiveness, which curtails pain by up to 50% and enhances patient’s quality of life. Apart from this, the results obtained from neurostimulation treatment can last a long time, thus fueling its application in pain management.

Country-wise Insights

Countries CAGR (2023 to 2033)
India 14.3%
United Kingdom 5.7%
China 12.4%
Australia 10.5%

High Profitable Prospects for Neurostimulation Devices in India

As per the study, India is predicted to witness a robust growth rate of 14.3% CAGR through 2033. The following factors are contributing to the sales of neurostimulation devices in the country:

  • Increasing adoption of advanced technologies to produce neurostimulators like responsive neurostimulation and magnetic neurostimulation that offer more efficiency, propelling sales of neurostimulation to treat various ailments.
  • Increasing cognizance and acceptance of neurostimulation in India as an alternate treatment for neurological disorders and chronic pain.

Research Breakthroughs in the United Kingdom to Propel Neurostimulation Market

The United Kingdom market is predicted to expand at a 5.7% CAGR over the forecast period. The country houses key players offering cutting-edge neurostimulation devices and enjoys early access to these latest innovations by healthcare professionals, indicating an already established market for neurostimulation. Therefore, the United Kingdom market is predicted to witness modest sales over the forecast period.  

The following factors are predicted to fuel market growth through 2033:

  • Constant developments of novel devices and technological upgrades by market participants and research affiliates, thus improving therapeutic outcomes and gaining a competitive edge in the market.
  • Key players are also targeting new markets for their innovations to boost their contribution to the global forum.

Remunerative Prospects in China Attracting Neurostimulation Key Providers

China is another lucrative market for neurostimulation devices in the Asia Pacific region, besides India. Given below are the leading factors that are supplementing market growth:

  • Ever-increasing population in China, particularly those suffering from health conditions, is creating a huge market for neurostimulation. Growth prospects are especially high for spinal cord stimulation (SCS) and deep brain stimulation (DBS) in China.
  • Growing awareness about neurostimulation as a viable treatment option for chronic pain and neurological disorders.

Investors Eyeing Australia as a Profitable Market for Neurostimulation Devices

Australia is predicted to expand at an impressive CAGR of 10.5% through 2033. Due to significant business opportunities in Australia, key players are investing in the country. Given below are the key factors that are spurring sales of neurostimulation:

  • Constantly rising geriatric population, which has a higher chance of developing neurological disorders like Alzheimer's disease, Parkinson's disease, and stroke.
  • Increasing support from the Australian government to develop and use neurostimulation devices via the Medical Research Future Fund (MRFF).

Market Outlook for Neurostimulation in Japan

The neurostimulation market in Japan is expanding at a healthy pace. This can be attributed to the following factors:

  • Japan has a rapidly rising aging population. Elderly people are susceptible to neurological disorders, which can be treated with the help of neurostimulation devices.
  • The government in Japan is highly committed to providing high-quality healthcare and the latest medical technology, which is predicted to be beneficial for the growth of the neurostimulation market.

Neurostimulation devices are finding high utilization by healthcare professionals in Japan for an effective pain management treatment. 

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Competitive Landscape in the Neurostimulation Market

Key players in the neurostimulation market are focusing on product development, which caters to more applications meanwhile enhancing these devices' efficiency, effectiveness, and user-friendliness. Apart from this, companies are leading clinical trials to test the efficacy and safety of their devices, boosting customer confidence and obtaining regulatory approvals for their neurostimulation devices.

Market participants are significantly investing in the sales and marketing of their product portfolio to healthcare professionals. This includes developing educational materials and exhibiting at trade shows for businesses. Additionally, companies are forming alliances with other players to extend their market reach as well as product portfolio.

Key Developments Observed in the Neurostimulation Market

  • In September 2023, a collaborative study including the universities of Surrey and Oxford, Radboud University, and Loughborough University was conducted to explore the scope of neurostimulation to boost mathematical learning. For this, high-frequency transcranial random noise stimulation was applied to stimulate certain brain regions and enhance the mathematical capabilities of participants. The research suggests a positive impact of brain stimulation on mathematical skills.
  • In April 2023, Neuspera Medical obtained FDA approval for a micro-implant neurostimulation therapy system. The system deploys a wearable device and a wireless platform for peripheral nerve stimulation.
  • In December 2022, the American Association for the Advancement of Science announced the development of new neurostimulation technology for advancements in the research and treatment of Parkinson’s disease. Latest innovations in DBS stimulators have opened doors to research the results of the recent DBS advances on Parkinson’s disease.

Key Players in the Neurostimulation Market

  • Boston Scientific Corporation
  • Cyberonics Inc.
  • St. Jude Medical Inc.
  • Medtronic Inc.
  • NeuroPace Inc.
  • NeuroSigma, Inc.
  • Others

Key Segments

By Type:

  • Spinal Cord Stimulators
  • Deep Brain Stimulators
  • Sacral Nerve Stimulators
  • Vagus Nerve Stimulators
  • Others

By Application:

  • Pain Management
  • Hearing Loss
  • Urinary Incontinence
  • Parkinson's disease
  • Epilepsy
  • Others

By Region:

  • North America
  • Latin America
  • Asia Pacific
  • Japan
  • Western Europe
  • Eastern Europe
  • Middle East & Africa

Frequently Asked Questions

How Big is the Neurostimulation Market?

The neurostimulation market is worth US$ 6,221.2 million in 2023.

What is the Growth Potential of the Neurostimulation Market?

The market is expected to expand at a CAGR of 9.5% through 2033.

What is the Future of the Neurostimulation Market?

The neurostimulation market is anticipated to account for US$ 15,417.4 million by 2033.

Which Country is Predicted to Witness Significant Growth?

India is predicted to witness significant growth.

Which Application Contributes Considerably to the Neurostimulation Market?

Pain management makes a significant contribution to the growth of the neurostimulation market.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand-side Trends

    1.3. Supply-side Trends

    1.4. Technology Roadmap Analysis

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

3. Market Background

    3.1. Market Dynamics

        3.1.1. Drivers

        3.1.2. Restraints

        3.1.3. Opportunity

        3.1.4. Trends

    3.2. Scenario Forecast

        3.2.1. Demand in Optimistic Scenario

        3.2.2. Demand in Likely Scenario

        3.2.3. Demand in Conservative Scenario

    3.3. Opportunity Map Analysis

    3.4. Product Life Cycle Analysis

    3.5. Supply Chain Analysis

        3.5.1. Supply Side Participants and their Roles

            3.5.1.1. Producers

            3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)

            3.5.1.3. Wholesalers and Distributors

        3.5.2. Value Added and Value Created at Node in the Supply Chain

        3.5.3. List of Raw Material Suppliers

        3.5.4. List of Existing and Potential Buyer’s

    3.6. Investment Feasibility Matrix

    3.7. Value Chain Analysis

        3.7.1. Profit Margin Analysis

        3.7.2. Wholesalers and Distributors

        3.7.3. Retailers

    3.8. PESTLE and Porter’s Analysis

    3.9. Regulatory Landscape

        3.9.1. By Key Regions

        3.9.2. By Key Countries

    3.10. Regional Parent Market Outlook

    3.11. Production and Consumption Statistics

    3.12. Import and Export Statistics

4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033

    4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022

    4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033

        4.2.1. Y-o-Y Growth Trend Analysis

        4.2.2. Absolute $ Opportunity Analysis

5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type

    5.1. Introduction / Key Findings

    5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Type, 2018 to 2022

    5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Type, 2023 to 2033

        5.3.1. Spinal Cord Stimulators

        5.3.2. Deep Brain Stimulators

        5.3.3. Sacral Nerve Stimulators

        5.3.4. Vagus Nerve Stimulators

        5.3.5. Others

    5.4. Y-o-Y Growth Trend Analysis By Type, 2018 to 2022

    5.5. Absolute $ Opportunity Analysis By Type, 2023 to 2033

6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application

    6.1. Introduction / Key Findings

    6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Application, 2018 to 2022

    6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Application, 2023 to 2033

        6.3.1. Pain Management

        6.3.2. Hearing Loss

        6.3.3. Urinary Incontinence

        6.3.4. Parkinson's disease

        6.3.5. Epilepsy

        6.3.6. Others

    6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022

    6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033

7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region

    7.1. Introduction

    7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022

    7.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033

        7.3.1. North America

        7.3.2. Latin America

        7.3.3. Western Europe

        7.3.4. Eastern Europe

        7.3.5. South Asia and Pacific

        7.3.6. East Asia

        7.3.7. Middle East and Africa

    7.4. Market Attractiveness Analysis By Region

8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    8.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    8.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        8.2.1. By Country

            8.2.1.1.USA

            8.2.1.2. Canada

        8.2.2. By Type

        8.2.3. By Application

    8.3. Market Attractiveness Analysis

        8.3.1. By Country

        8.3.2. By Type

        8.3.3. By Application

    8.4. Key Takeaways

9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        9.2.1. By Country

            9.2.1.1. Brazil

            9.2.1.2. Mexico

            9.2.1.3. Rest of Latin America

        9.2.2. By Type

        9.2.3. By Application

    9.3. Market Attractiveness Analysis

        9.3.1. By Country

        9.3.2. By Type

        9.3.3. By Application

    9.4. Key Takeaways

10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        10.2.1. By Country

            10.2.1.1. Germany

            10.2.1.2. UK

            10.2.1.3. France

            10.2.1.4. Spain

            10.2.1.5. Italy

            10.2.1.6. Rest of Western Europe

        10.2.2. By Type

        10.2.3. By Application

    10.3. Market Attractiveness Analysis

        10.3.1. By Country

        10.3.2. By Type

        10.3.3. By Application

    10.4. Key Takeaways

11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        11.2.1. By Country

            11.2.1.1. Poland

            11.2.1.2. Russia

            11.2.1.3. Czech Republic

            11.2.1.4. Romania

            11.2.1.5. Rest of Eastern Europe

        11.2.2. By Type

        11.2.3. By Application

    11.3. Market Attractiveness Analysis

        11.3.1. By Country

        11.3.2. By Type

        11.3.3. By Application

    11.4. Key Takeaways

12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        12.2.1. By Country

            12.2.1.1. India

            12.2.1.2. Bangladesh

            12.2.1.3. Australia

            12.2.1.4. New Zealand

            12.2.1.5. Rest of South Asia and Pacific

        12.2.2. By Type

        12.2.3. By Application

    12.3. Market Attractiveness Analysis

        12.3.1. By Country

        12.3.2. By Type

        12.3.3. By Application

    12.4. Key Takeaways

13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        13.2.1. By Country

            13.2.1.1. China

            13.2.1.2. Japan

            13.2.1.3. South Korea

        13.2.2. By Type

        13.2.3. By Application

    13.3. Market Attractiveness Analysis

        13.3.1. By Country

        13.3.2. By Type

        13.3.3. By Application

    13.4. Key Takeaways

14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country

    14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022

    14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033

        14.2.1. By Country

            14.2.1.1. GCC Countries

            14.2.1.2. South Africa

            14.2.1.3. Israel

            14.2.1.4. Rest of MEA

        14.2.2. By Type

        14.2.3. By Application

    14.3. Market Attractiveness Analysis

        14.3.1. By Country

        14.3.2. By Type

        14.3.3. By Application

    14.4. Key Takeaways

15. Key Countries Market Analysis

    15.1. USA

        15.1.1. Pricing Analysis

        15.1.2. Market Share Analysis, 2022

            15.1.2.1. By Type

            15.1.2.2. By Application

    15.2. Canada

        15.2.1. Pricing Analysis

        15.2.2. Market Share Analysis, 2022

            15.2.2.1. By Type

            15.2.2.2. By Application

    15.3. Brazil

        15.3.1. Pricing Analysis

        15.3.2. Market Share Analysis, 2022

            15.3.2.1. By Type

            15.3.2.2. By Application

    15.4. Mexico

        15.4.1. Pricing Analysis

        15.4.2. Market Share Analysis, 2022

            15.4.2.1. By Type

            15.4.2.2. By Application

    15.5. Germany

        15.5.1. Pricing Analysis

        15.5.2. Market Share Analysis, 2022

            15.5.2.1. By Type

            15.5.2.2. By Application

    15.6. UK

        15.6.1. Pricing Analysis

        15.6.2. Market Share Analysis, 2022

            15.6.2.1. By Type

            15.6.2.2. By Application

    15.7. France

        15.7.1. Pricing Analysis

        15.7.2. Market Share Analysis, 2022

            15.7.2.1. By Type

            15.7.2.2. By Application

    15.8. Spain

        15.8.1. Pricing Analysis

        15.8.2. Market Share Analysis, 2022

            15.8.2.1. By Type

            15.8.2.2. By Application

    15.9. Italy

        15.9.1. Pricing Analysis

        15.9.2. Market Share Analysis, 2022

            15.9.2.1. By Type

            15.9.2.2. By Application

    15.10. Poland

        15.10.1. Pricing Analysis

        15.10.2. Market Share Analysis, 2022

            15.10.2.1. By Type

            15.10.2.2. By Application

    15.11. Russia

        15.11.1. Pricing Analysis

        15.11.2. Market Share Analysis, 2022

            15.11.2.1. By Type

            15.11.2.2. By Application

    15.12. Czech Republic

        15.12.1. Pricing Analysis

        15.12.2. Market Share Analysis, 2022

            15.12.2.1. By Type

            15.12.2.2. By Application

    15.13. Romania

        15.13.1. Pricing Analysis

        15.13.2. Market Share Analysis, 2022

            15.13.2.1. By Type

            15.13.2.2. By Application

    15.14. India

        15.14.1. Pricing Analysis

        15.14.2. Market Share Analysis, 2022

            15.14.2.1. By Type

            15.14.2.2. By Application

    15.15. Bangladesh

        15.15.1. Pricing Analysis

        15.15.2. Market Share Analysis, 2022

            15.15.2.1. By Type

            15.15.2.2. By Application

    15.16. Australia

        15.16.1. Pricing Analysis

        15.16.2. Market Share Analysis, 2022

            15.16.2.1. By Type

            15.16.2.2. By Application

    15.17. New Zealand

        15.17.1. Pricing Analysis

        15.17.2. Market Share Analysis, 2022

            15.17.2.1. By Type

            15.17.2.2. By Application

    15.18. China

        15.18.1. Pricing Analysis

        15.18.2. Market Share Analysis, 2022

            15.18.2.1. By Type

            15.18.2.2. By Application

    15.19. Japan

        15.19.1. Pricing Analysis

        15.19.2. Market Share Analysis, 2022

            15.19.2.1. By Type

            15.19.2.2. By Application

    15.20. South Korea

        15.20.1. Pricing Analysis

        15.20.2. Market Share Analysis, 2022

            15.20.2.1. By Type

            15.20.2.2. By Application

    15.21. GCC Countries

        15.21.1. Pricing Analysis

        15.21.2. Market Share Analysis, 2022

            15.21.2.1. By Type

            15.21.2.2. By Application

    15.22. South Africa

        15.22.1. Pricing Analysis

        15.22.2. Market Share Analysis, 2022

            15.22.2.1. By Type

            15.22.2.2. By Application

    15.23. Israel

        15.23.1. Pricing Analysis

        15.23.2. Market Share Analysis, 2022

            15.23.2.1. By Type

            15.23.2.2. By Application

16. Market Structure Analysis

    16.1. Competition Dashboard

    16.2. Competition Benchmarking

    16.3. Market Share Analysis of Top Players

        16.3.1. By Regional

        16.3.2. By Type

        16.3.3. By Application

17. Competition Analysis

    17.1. Competition Deep Dive

        17.1.1. Boston Scientific Corporation

            17.1.1.1. Overview

            17.1.1.2. Product Portfolio

            17.1.1.3. Profitability by Market Segments

            17.1.1.4. Sales Footprint

            17.1.1.5. Strategy Overview

                17.1.1.5.1. Marketing Strategy

                17.1.1.5.2. Product Strategy

                17.1.1.5.3. Channel Strategy

        17.1.2. Cyberonics Inc.

            17.1.2.1. Overview

            17.1.2.2. Product Portfolio

            17.1.2.3. Profitability by Market Segments

            17.1.2.4. Sales Footprint

            17.1.2.5. Strategy Overview

                17.1.2.5.1. Marketing Strategy

                17.1.2.5.2. Product Strategy

                17.1.2.5.3. Channel Strategy

        17.1.3. St. Jude Medical Inc.

            17.1.3.1. Overview

            17.1.3.2. Product Portfolio

            17.1.3.3. Profitability by Market Segments

            17.1.3.4. Sales Footprint

            17.1.3.5. Strategy Overview

                17.1.3.5.1. Marketing Strategy

                17.1.3.5.2. Product Strategy

                17.1.3.5.3. Channel Strategy

        17.1.4. Medtronic Inc.

            17.1.4.1. Overview

            17.1.4.2. Product Portfolio

            17.1.4.3. Profitability by Market Segments

            17.1.4.4. Sales Footprint

            17.1.4.5. Strategy Overview

                17.1.4.5.1. Marketing Strategy

                17.1.4.5.2. Product Strategy

                17.1.4.5.3. Channel Strategy

        17.1.5. NeuroPace Inc.

            17.1.5.1. Overview

            17.1.5.2. Product Portfolio

            17.1.5.3. Profitability by Market Segments

            17.1.5.4. Sales Footprint

            17.1.5.5. Strategy Overview

                17.1.5.5.1. Marketing Strategy

                17.1.5.5.2. Product Strategy

                17.1.5.5.3. Channel Strategy

        17.1.6. NeuroSigma, Inc.

            17.1.6.1. Overview

            17.1.6.2. Product Portfolio

            17.1.6.3. Profitability by Market Segments

            17.1.6.4. Sales Footprint

            17.1.6.5. Strategy Overview

                17.1.6.5.1. Marketing Strategy

                17.1.6.5.2. Product Strategy

                17.1.6.5.3. Channel Strategy

        17.1.7. MED-EL GmbH

            17.1.7.1. Overview

            17.1.7.2. Product Portfolio

            17.1.7.3. Profitability by Market Segments

            17.1.7.4. Sales Footprint

            17.1.7.5. Strategy Overview

                17.1.7.5.1. Marketing Strategy

                17.1.7.5.2. Product Strategy

                17.1.7.5.3. Channel Strategy

        17.1.8. Synapse Biomedical Inc.

            17.1.8.1. Overview

            17.1.8.2. Product Portfolio

            17.1.8.3. Profitability by Market Segments

            17.1.8.4. Sales Footprint

            17.1.8.5. Strategy Overview

                17.1.8.5.1. Marketing Strategy

                17.1.8.5.2. Product Strategy

                17.1.8.5.3. Channel Strategy

        17.1.9. NDI Medical LLC

            17.1.9.1. Overview

            17.1.9.2. Product Portfolio

            17.1.9.3. Profitability by Market Segments

            17.1.9.4. Sales Footprint

            17.1.9.5. Strategy Overview

                17.1.9.5.1. Marketing Strategy

                17.1.9.5.2. Product Strategy

                17.1.9.5.3. Channel Strategy

        17.1.10. EnteroMedics Inc.

            17.1.10.1. Overview

            17.1.10.2. Product Portfolio

            17.1.10.3. Profitability by Market Segments

            17.1.10.4. Sales Footprint

            17.1.10.5. Strategy Overview

                17.1.10.5.1. Marketing Strategy

                17.1.10.5.2. Product Strategy

                17.1.10.5.3. Channel Strategy

        17.1.11. ImThera Medical

            17.1.11.1. Overview

            17.1.11.2. Product Portfolio

            17.1.11.3. Profitability by Market Segments

            17.1.11.4. Sales Footprint

            17.1.11.5. Strategy Overview

                17.1.11.5.1. Marketing Strategy

                17.1.11.5.2. Product Strategy

                17.1.11.5.3. Channel Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

Recommendations

Healthcare

Neurointerventional Device Market

Published : October 2023

Healthcare

MRI-Safe Neurostimulation Systems Market

Published : August 2023

Explore Healthcare Insights

View Reports